Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMDZ

Immune Design (IMDZ) Stock Price, News & Analysis

Immune Design logo

About Immune Design Stock (NASDAQ:IMDZ)

Advanced Chart

Key Stats

Today's Range
$5.85
$5.85
50-Day Range
$5.85
$5.85
52-Week Range
$1.10
$5.85
Volume
N/A
Average Volume
374,216 shs
Market Capitalization
$282.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMDZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immune Design and its competitors with MarketBeat's FREE daily newsletter.

IMDZ Stock News Headlines

Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
See More Headlines

IMDZ Stock Analysis - Frequently Asked Questions

Immune Design Corp. (NASDAQ:IMDZ) released its earnings results on Wednesday, August, 1st. The biotechnology company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.01. The biotechnology company had revenue of $0.76 million for the quarter, compared to analyst estimates of $0.64 million. Immune Design had a negative trailing twelve-month return on equity of 49.56% and a negative net margin of 2,483.00%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Immune Design investors own include Omeros (OMER), Progenics Pharmaceuticals (PGNX), Rigel Pharmaceuticals (RIGL), SCYNEXIS (SCYX), Selecta Biosciences (SELB), TG Therapeutics (TGTX) and TherapeuticsMD (TXMD).

Company Calendar

Last Earnings
8/01/2018
Today
7/19/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:IMDZ
CIK
1437786
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.75)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$54.76 million
Net Margins
-2,483.00%
Pretax Margin
N/A
Return on Equity
-49.56%
Return on Assets
-46.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
11.33
Quick Ratio
11.32

Sales & Book Value

Annual Sales
$2.20 million
Price / Sales
128.62
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.91 per share
Price / Book
3.06

Miscellaneous

Outstanding Shares
48,370,000
Free Float
N/A
Market Cap
$282.96 million
Optionable
Optionable
Beta
3.48
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:IMDZ) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners